What is Foghorn Therapeutics Inc. Common Stock's Market Cap?

Foghorn Therapeutics Inc. Common Stock's Market Cap is $286.8M, based on as-reported figures from SEC (XBRL) filings.

What is Foghorn Therapeutics Inc. Common Stock's Price / Sales?

Foghorn Therapeutics Inc. Common Stock's Price / Sales is 7.8×, based on as-reported figures from SEC (XBRL) filings.

What is Foghorn Therapeutics Inc. Common Stock's Revenue (TTM)?

Foghorn Therapeutics Inc. Common Stock's Revenue (TTM) is $36.7M, based on as-reported figures from SEC (XBRL) filings.

What is Foghorn Therapeutics Inc. Common Stock's Net Income (TTM)?

Foghorn Therapeutics Inc. Common Stock's Net Income (TTM) is -$64.6M, based on as-reported figures from SEC (XBRL) filings.

What is Foghorn Therapeutics Inc. Common Stock's EBITDA?

Foghorn Therapeutics Inc. Common Stock's EBITDA is -$70.6M, based on as-reported figures from SEC (XBRL) filings.

What is Foghorn Therapeutics Inc. Common Stock's Diluted EPS (TTM)?

Foghorn Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -1.09, based on as-reported figures from SEC (XBRL) filings.

What is Foghorn Therapeutics Inc. Common Stock's EBITDA Margin?

Foghorn Therapeutics Inc. Common Stock's EBITDA Margin is -192.3%, based on as-reported figures from SEC (XBRL) filings.

Foghorn Therapeutics Inc. Common Stock (FHTX) Financial Statements

Foghorn Therapeutics Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00HFZPB97

XNAS · usd

4.83▼ 0.09 (-1.83%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close4.92

Day's Range4.66 – 4.91

52-Week Range3.27 – 7.61

Volume219.3K

Avg Volume333.5K

Share Statistics

Shares Outstanding

Employees106

ExchangeXNAS

Listed2020-10-23

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Foghorn Therapeutics Inc. Common Stock (FHTX)

What is Foghorn Therapeutics Inc. Common Stock's Market Cap?: Foghorn Therapeutics Inc. Common Stock's Market Cap is $286.8M, based on as-reported figures from SEC (XBRL) filings.
What is Foghorn Therapeutics Inc. Common Stock's Price / Sales?: Foghorn Therapeutics Inc. Common Stock's Price / Sales is 7.8×, based on as-reported figures from SEC (XBRL) filings.
What is Foghorn Therapeutics Inc. Common Stock's Revenue (TTM)?: Foghorn Therapeutics Inc. Common Stock's Revenue (TTM) is $36.7M, based on as-reported figures from SEC (XBRL) filings.
What is Foghorn Therapeutics Inc. Common Stock's Net Income (TTM)?: Foghorn Therapeutics Inc. Common Stock's Net Income (TTM) is -$64.6M, based on as-reported figures from SEC (XBRL) filings.
What is Foghorn Therapeutics Inc. Common Stock's EBITDA?: Foghorn Therapeutics Inc. Common Stock's EBITDA is -$70.6M, based on as-reported figures from SEC (XBRL) filings.
What is Foghorn Therapeutics Inc. Common Stock's Diluted EPS (TTM)?: Foghorn Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -1.09, based on as-reported figures from SEC (XBRL) filings.
What is Foghorn Therapeutics Inc. Common Stock's EBITDA Margin?: Foghorn Therapeutics Inc. Common Stock's EBITDA Margin is -192.3%, based on as-reported figures from SEC (XBRL) filings.